A detailed history of Norden Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Norden Group LLC holds 8,995 shares of AZN stock, worth $597,268. This represents 0.08% of its overall portfolio holdings.

Number of Shares
8,995
Previous 4,932 82.38%
Holding current value
$597,268
Previous $385 Million 82.19%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$76.67 - $87.62 $311,510 - $356,000
4,063 Added 82.38%
8,995 $701 Million
Q2 2024

Aug 06, 2024

BUY
$66.81 - $80.83 $78,501 - $94,975
1,175 Added 31.27%
4,932 $385 Million
Q1 2024

Apr 30, 2024

SELL
$61.03 - $69.57 $2.52 Million - $2.88 Million
-41,327 Reduced 91.67%
3,757 $255 Million
Q1 2024

Apr 19, 2024

BUY
$61.03 - $69.57 $2.75 Million - $3.14 Million
45,084 New
45,084 $3.05 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.